. Enfin, certains mécanismes physiopathologiques entrainant l'atteinte cérébrale de cette pathologie restent à ce jour insuffisamment compris Une des voies à explorer davantage est l'accumulation cérébrale de métabolites neurotoxiques. Or, plusieurs kynurénines possèdent des propriétés neuroactives, que ce soit par l'action

E. Hényková, H. Vránová, P. Amakorová, T. Pospí?il, A. ?ukauskait? et al., Stable isotope dilution ultra-high performance liquid chromatography???tandem mass spectrometry quantitative profiling of tryptophan-related neuroactive substances in human serum and cerebrospinal fluid, Journal of Chromatography A, vol.1437, pp.145-57, 2016.
DOI : 10.1016/j.chroma.2016.02.009

N. King and S. Thomas, Molecules in focus: Indoleamine 2,3-dioxygenase, The International Journal of Biochemistry & Cell Biology, vol.39, issue.12, pp.2167-72, 2007.
DOI : 10.1016/j.biocel.2007.01.004

R. Metz, J. Duhadaway, U. Kamasani, L. Laury-kleintop, A. Muller et al., Novel Tryptophan Catabolic Enzyme IDO2 Is the Preferred Biochemical Target of the Antitumor Indoleamine 2,3-Dioxygenase Inhibitory Compound D-1-Methyl-Tryptophan, Cancer Research, vol.67, issue.15, pp.7082-7089, 2007.
DOI : 10.1158/0008-5472.CAN-07-1872

I. Kema, E. De-vries, and F. Muskiet, Clinical chemistry of serotonin and metabolites, Journal of Chromatography B: Biomedical Sciences and Applications, vol.747, issue.1-2, pp.33-48, 2000.
DOI : 10.1016/S0378-4347(00)00341-8

R. Reiter, Melatonin: The chemical expression of darkness, Molecular and Cellular Endocrinology, vol.79, issue.1-3, pp.153-161, 1991.
DOI : 10.1016/0303-7207(91)90087-9

D. Keszthelyi, F. Troost, and A. Masclee, Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function, Neurogastroenterology & Motility, vol.36, issue.12, pp.1239-1288, 2009.
DOI : 10.1111/j.1572-0241.2006.00811.x

P. Niinisalo, A. Raitala, M. Pertovaara, S. Oja, T. Lehtimäki et al., Indoleamine 2,3???dioxygenase activity associates with cardiovascular risk factors: The Health 2000 study, Scandinavian Journal of Clinical and Laboratory Investigation, vol.45, issue.8, pp.767-70, 2008.
DOI : 10.1161/01.ATV.0000245830.29764.84

R. Ocampo, J. , L. Huitrón, R. González-esquivel, D. Ugalde-muñiz et al., Kynurenines with Neuroactive and Redox Properties: Relevance to Aging and Brain Diseases, Kynurenines with Neuroactive and Redox Properties: Relevance to Aging and Brain Diseases, pp.1-22, 2014.
DOI : 10.1017/S0033291701004007

Y. Zhang, J. Shen, X. He, K. Zhang, S. Wu et al., A Rare Variant at the KYNU Gene Is Associated With Kynureninase Activity and Essential Hypertension in the Han Chinese Population, Circulation: Cardiovascular Genetics, vol.4, issue.6, pp.687-94, 2011.
DOI : 10.1161/CIRCGENETICS.110.959064

L. Boulet, F. P. , L. Gouellec, A. Toussaint, B. Pépin et al., Is tryptophan metabolism involved in sleep apnea-related cardiovascular co-morbidities and cancer progression? Med Hypotheses, oct, vol.85, issue.4, pp.415-438, 2015.
DOI : 10.1016/j.mehy.2015.06.022

H. Mangge, K. Summers, A. Meinitzer, S. Zelzer, G. Almer et al., Obesity-related dysregulation of the Tryptophan-Kynurenine metabolism: Role of age and parameters of the metabolic syndrome, Obesity, vol.1199, issue.Suppl 2, pp.195-201, 2014.
DOI : 10.1111/j.1749-6632.2009.05355.x

B. Wirleitner, V. Rudzite, G. Neurauter, C. Murr, U. Kalnins et al., Immune activation and degradation of tryptophan in coronary heart disease, European Journal of Clinical Investigation, vol.21, issue.7, pp.550-554, 2003.
DOI : 10.1515/pteridines.2001.12.3.126

G. Sulo, S. Vollset, O. Nygård, Ø. Midttun, P. Ueland et al., Neopterin and kynurenine???tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study, International Journal of Cardiology, vol.168, issue.2, pp.1435-1475, 2013.
DOI : 10.1016/j.ijcard.2012.12.090

M. Pertovaara, A. Raitala, M. Juonala, T. Lehtimäki, H. Huhtala et al., Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study, Clinical & Experimental Immunology, vol.52, issue.Suppl., pp.106-117, 2007.
DOI : 10.1016/S0171-2985(00)80079-0

K. Pawlak, M. My?liwiec, and D. Pawlak, Kynurenine pathway ??? a new link between endothelial dysfunction and carotid atherosclerosis in chronic kidney disease patients, Advances in Medical Sciences, vol.55, issue.2, pp.196-203, 2010.
DOI : 10.2478/v10039-010-0015-6

K. Mizutani, K. Sugimoto, T. Okuda, T. Katsuya, T. Miyata et al., Kynureninase Is a Novel Candidate Gene for Hypertension in Spontaneously Hypertensive Rats, Hypertension Research, vol.25, issue.1, pp.135-175, 2002.
DOI : 10.1291/hypres.25.135

J. Kwok, R. Kapoor, T. Gotoda, Y. Iwamoto, Y. Iizuka et al., A Missense Mutation in Kynurenine Aminotransferase-1 in Spontaneously Hypertensive Rats, Journal of Biological Chemistry, vol.3, issue.39, pp.35779-82, 2002.
DOI : 10.1016/0014-5793(95)00123-Q

G. Ristagno, R. Latini, J. Vaahersalo, S. Masson, J. Kurola et al., Early Activation of the Kynurenine Pathway Predicts Early Death and Long-term Outcome in Patients Resuscitated From Out-of-Hospital Cardiac Arrest, J Am Heart Assoc. 4 août, vol.3, issue.4, p.1094, 2014.

D. Munn, M. Zhou, J. Attwood, I. Bondarev, S. Conway et al., Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism, Science, vol.281, issue.5380, pp.1191-1194, 1998.
DOI : 10.1126/science.281.5380.1191

G. Prendergast, C. Smith, S. Thomas, L. Mandik-nayak, L. Laury-kleintop et al., Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer, Cancer Immunology, Immunotherapy, vol.17, issue.9, pp.721-756, 2014.
DOI : 10.1038/nm.2438

G. Frumento, R. Rotondo, M. Tonetti, G. Damonte, U. Benatti et al., Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-Dioxygenase, The Journal of Experimental Medicine, vol.242, issue.4, pp.459-68, 2002.
DOI : 10.4049/jimmunol.164.7.3596

I. Murray, A. Patterson, and G. Perdew, Aryl hydrocarbon receptor ligands in cancer: friend and foe, Nature Reviews Cancer, vol.276, issue.12, pp.801-815, 2014.
DOI : 10.1038/nrc3846

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401080/pdf

F. Halberg and . Chronobiology, Chronobiology, Annual Review of Physiology, vol.31, issue.1, pp.675-725, 1969.
DOI : 10.1146/annurev.ph.31.030169.003331

G. Réus, K. Jansen, S. Titus, A. Carvalho, V. Gabbay et al., Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies, Journal of Psychiatric Research, vol.68, pp.316-344, 2015.
DOI : 10.1016/j.jpsychires.2015.05.007

B. Campbell, E. Charych, A. Lee, and T. Möller, Kynurenines in CNS disease: regulation by inflammatory cytokines, Frontiers in Neuroscience, vol.8, p.12, 2014.
DOI : 10.3389/fnins.2014.00012

URL : http://journal.frontiersin.org/article/10.3389/fnins.2014.00012/pdf

. Kegel, M. Bhat, E. Skogh, M. Samuelsson, K. Lundberg et al., Imbalanced Kynurenine Pathway in Schizophrenia, International Journal of Tryptophan Research, vol.15, 2014.
DOI : 10.4137/IJTR.S16800

URL : https://doi.org/10.4137/ijtr.s16800

C. Lim, M. Essa, R. De-paula-martins, D. Lovejoy, A. Bilgin et al., Altered kynurenine pathway metabolism in autism: Implication for immune-induced glutamatergic activity, Autism Research, vol.49, issue.6, pp.621-652, 2016.
DOI : 10.1136/jmedgenet-2012-101203

L. Darlington, G. Mackay, C. Forrest, N. Stoy, C. George et al., Altered kynurenine metabolism correlates with infarct volume in stroke, European Journal of Neuroscience, vol.26, issue.8, pp.2211-2232, 2007.
DOI : 10.1042/bj2620861

L. Gellért, J. Fuzik, A. Göblös, K. Sárközi, M. Marosi et al., Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia, European Journal of Pharmacology, vol.667, issue.1-3, pp.182-189, 2011.
DOI : 10.1016/j.ejphar.2011.05.069

G. Battaglia, L. Russa, M. Bruno, V. Arenare, L. Ippolito et al., Systemically administered d-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents, Brain Research, vol.860, issue.1-2, pp.149-56, 2000.
DOI : 10.1016/S0006-8993(00)01962-4

L. Vécsei, L. Szalárdy, F. Fülöp, and J. Toldi, Kynurenines in the CNS: recent advances and new questions, Nature Reviews Drug Discovery, vol.18, issue.1, pp.64-82, 2012.
DOI : 10.1177/1352458512450354

J. Dwarkasing, R. Witkamp, M. Boekschoten, T. Laak, M. Heins et al., Increased hypothalamic serotonin turnover in inflammation-induced anorexia, BMC Neuroscience, vol.7, issue.2, p.26, 2016.
DOI : 10.1186/1471-2105-7-538

URL : https://bmcneurosci.biomedcentral.com/track/pdf/10.1186/s12868-016-0260-0?site=bmcneurosci.biomedcentral.com

K. Zhang, Y. Zhu, Y. Zhu, S. Wu, H. Liu et al., Molecular, Functional, and Structural Imaging of Major Depressive Disorder, Neuroscience Bulletin, vol.162, issue.3, pp.273-85, 2016.
DOI : 10.1016/j.pscychresns.2007.08.008

M. Berger, J. Gray, and B. Roth, The Expanded Biology of Serotonin, Annual Review of Medicine, vol.60, issue.1, pp.355-66, 2009.
DOI : 10.1146/annurev.med.60.042307.110802

B. Chakraborti, D. Verma, A. Karmakar, P. Jaiswal, A. Sanyal et al., Genetic variants of MAOB affect serotonin level and specific behavioral attributes to increase autism spectrum disorder (ASD) susceptibility in males, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.71, pp.123-159, 2016.
DOI : 10.1016/j.pnpbp.2016.07.001

C. Marcinkiewcz, E. Lowery-gionta, and T. Kash, Serotonin's Complex Role in Alcoholism: Implications for Treatment and Future Research, Alcoholism: Clinical and Experimental Research, vol.35, issue.Pt 1, pp.1192-201, 2016.
DOI : 10.1111/j.1460-9568.2012.08037.x

W. Hooten, Chronic Pain and Mental Health Disorders, Mayo Clinic Proceedings, vol.91, issue.7, pp.955-70, 2016.
DOI : 10.1016/j.mayocp.2016.04.029

S. Comai, A. Bertazzo, J. Vachon, M. Daigle, J. Toupin et al., Tryptophan via serotonin/kynurenine pathways abnormalities in a large cohort of aggressive inmates: markers for aggression, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.70, pp.8-16, 2016.
DOI : 10.1016/j.pnpbp.2016.04.012

P. De-deurwaerdère, D. Giovanni, and G. , Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications, Progress in Neurobiology, vol.151, 2016.
DOI : 10.1016/j.pneurobio.2016.03.004

R. Hardeland, Neurobiology, Pathophysiology, and Treatment of Melatonin Deficiency and Dysfunction, The Scientific World Journal, vol.19, issue.4-5, p.640389, 2012.
DOI : 10.3928/02793695-20110809-01

URL : http://doi.org/10.1100/2012/640389

W. De-herder, Biochemistry of neuroendocrine tumours, Best Practice & Research Clinical Endocrinology & Metabolism, vol.21, issue.1, pp.33-41, 2007.
DOI : 10.1016/j.beem.2006.12.002

D. Walther, J. Peter, S. Bashammakh, H. Hörtnagl, M. Voits et al., Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform, Science, vol.299, issue.5603, p.76, 2003.
DOI : 10.1126/science.1078197

V. Mosienko, D. Beis, M. Pasqualetti, J. Waider, S. Matthes et al., Life without brain serotonin: Reevaluation of serotonin function with mice deficient in brain serotonin synthesis, Behavioural Brain Research, vol.277, pp.78-88, 2015.
DOI : 10.1016/j.bbr.2014.06.005

S. Camargo, D. Bockenhauer, and R. Kleta, Aminoacidurias: Clinical and molecular aspects, Kidney International, vol.73, issue.8, pp.918-925, 2008.
DOI : 10.1038/sj.ki.5002790

URL : https://doi.org/10.1038/sj.ki.5002790

C. Marecos, J. Ng, and M. Kurian, What is new for monoamine neurotransmitter disorders?, Journal of Inherited Metabolic Disease, vol.75, issue.2, pp.619-645, 2014.
DOI : 10.1006/mgme.2001.3273

L. Brun, L. Ngu, W. Keng, G. Ch-'ng, Y. Choy et al., Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency, Neurology, vol.75, issue.1, pp.64-71, 2010.
DOI : 10.1212/WNL.0b013e3181e620ae

B. Cellini, R. Montioli, E. Oppici, and C. Voltattorni, Biochemical and Computational Approaches to Improve the Clinical Treatment of Dopa Decarboxylase-Related Diseases: An Overview, The Open Biochemistry Journal, vol.6, issue.1, pp.131-139, 2012.
DOI : 10.2174/1874091X01206010131

M. Christensen, M. Duno, A. Lund, F. Skovby, and E. Christensen, Xanthurenic aciduria due to a mutation in KYNU encoding kynureninase, Journal of Inherited Metabolic Disease, vol.52, issue.2, pp.248-55, 2007.
DOI : 10.1007/978-1-4684-5952-4_32

J. Martin, C. Mellor, and F. Fraser, Familial hypertryptophanemia in two siblings, Clinical Genetics, vol.10, issue.S51, pp.180-183, 1995.
DOI : 10.1203/00006450-197608000-00005

W. Snedden, C. Mellor, and J. Martin, Familial hypertryptophanemia, tryptophanuria and indoleketonuria, Clinica Chimica Acta, vol.131, issue.3, pp.247-56, 1983.
DOI : 10.1016/0009-8981(83)90094-3

P. Clayton, N. Bridges, D. Atherton, P. Milla, M. Malone et al., Pellagra with colitis due to a defect in tryptophan metabolism, European Journal of Pediatrics, vol.10, issue.7, pp.498-502, 1991.
DOI : 10.1097/00007611-198306000-00015

M. Salih, D. Bender, and G. Mccreanor, Lethal familial pellagra-like skin lesion associated with neurologic and developmental impairment and the development of cataracts, Pediatrics. nov, vol.76, issue.5, pp.787-93, 1985.

S. Kölker, S. Garbade, C. Greenberg, J. Leonard, J. Saudubray et al., Natural History, Outcome, and Treatment Efficacy in Children and Adults with Glutaryl-CoA Dehydrogenase Deficiency, Pediatric Research, vol.27, issue.6, pp.840-847, 2006.
DOI : 10.1023/B:BOLI.0000045773.07785.83

S. Varadkar and R. Surtees, Glutaric aciduria type I and kynurenine pathway metabolites: A modified hypothesis, Journal of Inherited Metabolic Disease, vol.27, issue.6, pp.835-877, 2004.
DOI : 10.1023/B:BOLI.0000045767.42193.97

P. Maciejak, J. Szyndler, D. Turzy?ska, A. Sobolewska, K. Ko?osowska et al., Is the interaction between fatty acids and tryptophan responsible for the efficacy of a ketogenic diet in epilepsy? The new hypothesis of action, Neuroscience, vol.313, pp.130-178, 2016.
DOI : 10.1016/j.neuroscience.2015.11.029

J. Benoist, Introduction au métabolisme des acides aminés. DIU Maladies Héréditaires du Métabolisme, 2014.

M. Möller, D. Preez, J. Harvey, and B. , Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma, Journal of Chromatography B, vol.898, pp.121-130, 2012.
DOI : 10.1016/j.jchromb.2012.04.030

Y. Huang, A. Louie, Q. Yang, N. Massenkoff, C. Xu et al., A simple LC???MS/MS method for determination of kynurenine and tryptophan concentrations in human plasma from HIV-infected patients, Bioanalysis, vol.48, issue.11, pp.1397-407, 2013.
DOI : 10.4155/bio.11.315

W. Jong, R. Smit, S. Bakker, E. De-vries, and I. Kema, Plasma tryptophan, kynurenine and 3-hydroxykynurenine measurement using automated on-line solid-phase extraction HPLC???tandem mass spectrometry, Journal of Chromatography B, vol.877, issue.7, pp.603-612, 2009.
DOI : 10.1016/j.jchromb.2009.01.015

Ø. Midttun, S. Hustad, and P. Ueland, Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry, Rapid Communications in Mass Spectrometry, vol.527, issue.9, pp.1371-1380, 2009.
DOI : 10.1007/978-1-4615-0135-0_32

K. Yamada, T. Miyazaki, T. Shibata, N. Hara, and M. Tsuchiya, Simultaneous measurement of tryptophan and related compounds by liquid chromatography/electrospray ionization tandem mass spectrometry, Journal of Chromatography B, vol.867, issue.1, pp.57-61, 2008.
DOI : 10.1016/j.jchromb.2008.03.010

A. Kato, Y. Suzuki, T. Suda, M. Suzuki, M. Fujie et al., Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patients, Hemodialysis International, vol.36, issue.4, pp.418-442, 2010.
DOI : 10.4049/jimmunol.179.8.5246

L. Orsatti, R. Speziale, M. Orsale, F. Caretti, M. Veneziano et al., A single-run liquid chromatography mass spectrometry method to quantify neuroactive kynurenine pathway metabolites in rat plasma, Journal of Pharmaceutical and Biomedical Analysis, vol.107, pp.426-457, 2015.
DOI : 10.1016/j.jpba.2015.01.030

W. Zhu, A. Stevens, K. Dettmer, E. Gottfried, S. Hoves et al., Quantitative profiling of tryptophan metabolites in serum, urine, and cell culture supernatants by liquid chromatography???tandem mass spectrometry, Analytical and Bioanalytical Chemistry, vol.117, issue.10, pp.3249-61, 2011.
DOI : 10.1172/JCI31178

H. Ohashi, H. Iizuka, S. Yoshihara, H. Otani, M. Kume et al., Determination of Ltryptophan and L-kynurenine in Human Serum by using LC-MS after Derivatization with (R)- DBD-PyNCS, Int J Tryptophan Res. juill, vol.9, 2013.

F. Notarangelo, H. Wu, A. Macherone, D. Graham, and R. Schwarcz, Gas chromatography/tandem mass spectrometry detection of extracellular kynurenine and related metabolites in normal and lesioned rat brain, Analytical Biochemistry, vol.421, issue.2, pp.573-81, 2012.
DOI : 10.1016/j.ab.2011.12.032

C. Forrest, G. Mackay, N. Stoy, S. Spiden, R. Taylor et al., Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington???s disease, Journal of Neurochemistry, vol.102, issue.1, pp.112-134, 2010.
DOI : 10.1097/00001756-199406020-00026

L. Kolodziej, Investigation of the kynurenine pathway in Indoleamine 2, 3 dioxygenase deficient mice with inflammatory arthritis, Transgenic Research, vol.56, issue.12, pp.1049-54, 2013.
DOI : 10.1002/art.23138

A. Laich, G. Neurauter, B. Widner, and D. Fuchs, More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC, Clin Chem. mars, vol.48, issue.3, pp.579-81, 2002.

A. Amirkhani, E. Heldin, K. Markides, and J. Bergquist, Quantitation of tryptophan, kynurenine and kynurenic acid in human plasma by capillary liquid chromatography???electrospray ionization tandem mass spectrometry, Journal of Chromatography B, vol.780, issue.2, pp.381-388, 2002.
DOI : 10.1016/S1570-0232(02)00572-X

B. Arvidsson, N. Johannesson, A. Citterio, P. Righetti, and J. Bergquist, High throughput analysis of tryptophan metabolites in a complex matrix using capillary electrophoresis coupled to time-of-flight mass spectrometry, Journal of Chromatography A, vol.1159, issue.1-2, pp.154-162, 2007.
DOI : 10.1016/j.chroma.2007.04.044

Y. Sakaguchi, J. Ikenaga, H. Yoshida, T. Hayama, M. Itoyama et al., Selective and sensitive liquid chromatographic determination method of 5-hydroxyindoles with fluorous and fluorogenic derivatization, Journal of Pharmaceutical and Biomedical Analysis, vol.114, pp.348-54, 2015.
DOI : 10.1016/j.jpba.2015.06.003

I. Kema, W. Meijer, G. Meiborg, B. Ooms, P. Willemse et al., Profiling of tryptophanrelated plasma indoles in patients with carcinoid tumors by automated, on-line, solid-phase extraction and HPLC with fluorescence detection, Clin Chem, vol.47, issue.10, pp.1811-1831, 2001.

A. Vaarmann, A. Kask, and U. Mäeorg, Novel and sensitive high-performance liquid chromatographic method based on electrochemical coulometric array detection for simultaneous determination of catecholamines, kynurenine and indole derivatives of tryptophan, Journal of Chromatography B, vol.769, issue.1, pp.145-53, 2002.
DOI : 10.1016/S1570-0232(01)00639-0

J. Zagajewski, D. Drozdowicz, I. Brzozowska, M. Hubalewska-mazgaj, T. Stelmaszynska et al., Conversion L-tryptophan to melatonin in the gastrointestinal tract: the new high performance liquid chromatography method enabling simultaneous determination of six metabolites of L-tryptophan by native fluorescence and UV?VIS detection, J Physiol Pharmacol, vol.63, issue.6, pp.613-634, 2012.

J. Zhao, H. Chen, P. Ni, B. Xu, X. Luo et al., Simultaneous determination of urinary tryptophan, tryptophan-related metabolites and creatinine by high performance liquid chromatography with ultraviolet and fluorimetric detection, Journal of Chromatography B, vol.879, issue.26, pp.2720-2725, 2011.
DOI : 10.1016/j.jchromb.2011.07.035

W. Lesniak, J. A. Mishra, M. Louissaint, N. Romero, R. Chugani et al., Concurrent quantification of tryptophan and its major metabolites, Analytical Biochemistry, vol.443, issue.2, pp.222-253, 2013.
DOI : 10.1016/j.ab.2013.09.001

H. Lu, Y. J. Wang, J. Wu, L. Xiao, H. Gao et al., Simultaneous quantification of neuroactive dopamine serotonin and kynurenine pathway metabolites in gender-specific youth urine by ultra performance liquid chromatography tandem high resolution mass spectrometry, Journal of Pharmaceutical and Biomedical Analysis, vol.122, pp.42-51, 2016.
DOI : 10.1016/j.jpba.2016.01.031

M. Sano, V. Ferchaud-roucher, C. Nael, A. Aguesse, G. Poupeau et al., -kynurenine, serotonin and quinolinic acid, by gas chromatography/negative ion chemical ionization mass spectrometry, Journal of Mass Spectrometry, vol.4, issue.2, pp.128-163, 2014.
DOI : 10.1042/cs0900457

J. Galba, A. Michalicova, V. Parrak, M. Novak, and A. Kovac, Quantitative analysis of phenylalanine, tyrosine, tryptophan and kynurenine in rat model for tauopathies by ultra-high performance liquid chromatography with fluorescence and mass spectrometry detection, Journal of Pharmaceutical and Biomedical Analysis, vol.117, pp.85-90, 2015.
DOI : 10.1016/j.jpba.2015.08.026

J. Marcos, N. Renau, O. Valverde, G. Aznar-laín, I. Gracia-rubio et al., Targeting tryptophan and tyrosine metabolism by liquid chromatography tandem mass spectrometry, Journal of Chromatography A, vol.1434, pp.91-101, 2016.
DOI : 10.1016/j.chroma.2016.01.023

A. Badawy and C. Morgan, Rapid Isocratic Liquid Chromatographic Separation and Quantification of Tryptophan and Six kynurenine Metabolites in Biological Samples with Ultraviolet and Fluorimetric Detection, International Journal of Tryptophan Research, vol.175, 2010.
DOI : 10.4137/IJTR.S6225

J. Kuligowski, D. Sanjuan-herráez, M. Vázquez-sánchez, A. Brunet-vega, C. Pericay et al., Metabolomic Analysis of Gastric Cancer Progression within the Correa???s Cascade Using Ultraperformance Liquid Chromatography???Mass Spectrometry, Journal of Proteome Research, vol.15, issue.8, pp.2729-2767, 2016.
DOI : 10.1021/acs.jproteome.6b00281

J. Galba, A. Michalicova, V. Parrak, M. Novak, and A. Kovac, Quantitative analysis of phenylalanine, tyrosine, tryptophan and kynurenine in rat model for tauopathies by ultra-high performance liquid chromatography with fluorescence and mass spectrometry detection, Journal of Pharmaceutical and Biomedical Analysis, vol.117, pp.85-90, 2016.
DOI : 10.1016/j.jpba.2015.08.026

I. Følling, The discovery of phenylketonuria, Acta Paediatrica, vol.949, issue.s407, pp.4-10, 1992.
DOI : 10.1021/cr60116a002

H. Bickel, G. J. Hickmans, and E. , Influence of phenylalanine intake on phenylketonuria, Lancet. 17 oct, vol.265, issue.6790, pp.812-815, 1953.

J. Wilson and G. Jungner, Principes et pratique du dépistage des maladies. Organisation Mondiale de la Santé, 1970.

R. Guthrie and A. Susi, A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants, Pediatrics. sept, vol.32, pp.338-381, 1963.

H. Autorité and D. Santé, Phénylcétonurie, Protocole national de diagnostic et de soins, 2010.

F. Schuck, P. Malgarin, F. , H. Cararo, J. Cardoso et al., Phenylketonuria Pathophysiology: on the Role of Metabolic Alterations, Aging and Disease, vol.6, issue.5, p.390, 2015.
DOI : 10.14336/AD.2015.0827

J. Saudubray, G. Van-den-berghe, and J. Walter, Inborn Metabolic Diseases : Diagnosis and Treatment, 2012.

N. Blau, Genetics of Phenylketonuria: Then and Now, Human Mutation, vol.29, issue.12 Suppl, pp.508-523, 2016.
DOI : 10.1002/humu.20637

T. Opladen, G. Hoffmann, and N. Blau, An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia, Journal of Inherited Metabolic Disease, vol.39, issue.6, pp.963-73, 2012.
DOI : 10.1212/WNL.39.5.673

S. Richardson, R. Aspbury, and M. Fisher, The role of reversible phosphorylation in the hormonal control of phenylalanine hydroxylase in isolated rat proximal kidney tubules, Biochemical Journal, vol.292, issue.2, pp.419-443, 1993.
DOI : 10.1042/bj2920419

S. Hufton, I. Jennings, and R. Cotton, Structure and function of the aromatic amino acid hydroxylases, Biochemical Journal, vol.311, issue.2, pp.353-66, 1995.
DOI : 10.1042/bj3110353

R. Williams, C. Mamotte, and J. Burnett, Phenylketonuria: an inborn error of phenylalanine metabolism. metabolism, p.13, 2008.

D. Konecki, Y. Wang, F. Trefz, U. Lichter-konecki, and S. Woo, Structural characterization of the 5' regions of the human phenylalanine hydroxylase gene, Biochemistry, vol.31, issue.35, pp.8363-8371, 1992.
DOI : 10.1021/bi00150a033

. Biopku, PAH genomic structure and variants

T. Moraes, C. Jacques, A. Rosa, G. Dalazen, M. Terra et al., Role of Catalase and Superoxide Dismutase Activities on Oxidative Stress in the Brain of a Phenylketonuria Animal Model and the Effect of Lipoic Acid, Cellular and Molecular Neurobiology, vol.13, issue.3, pp.253-60, 2013.
DOI : 10.1093/carcin/13.8.1485

P. Justice and D. Hsia, Studies on Inhibition of Brain 5-Hydroxytryptophan Decarboxylase by Phenylalanine Metabolites., Experimental Biology and Medicine, vol.118, issue.2, pp.326-334, 1965.
DOI : 10.3181/00379727-118-29833

A. Hood, J. Antenor-dorsey, J. Rutlin, T. Hershey, J. Shimony et al., Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria, Molecular Genetics and Metabolism, vol.114, issue.1, pp.19-24, 2015.
DOI : 10.1016/j.ymgme.2014.11.007

V. Rech, L. Feksa, C. Dutra-filho, A. Wyse, S. Wajner et al., Inhibition of the mitochondrial respiratory chain by phenylalanine in rat cerebral cortex, Neurochemical Research, vol.27, issue.5, pp.353-360, 2002.
DOI : 10.1023/A:1015529511664

S. Waisbren, M. Brown, L. De-sonneville, and H. Levy, Review of neuropsychological functioning in treated phenylketonuria: an information processing approach, Acta Paediatrica, vol.14, issue.s407, pp.98-103, 1994.
DOI : 10.1212/WNL.26.10.1000

R. Jahja, F. Van-spronsen, L. De-sonneville, J. Van-der-meere, A. Bosch et al., Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study, Journal of Inherited Metabolic Disease, vol.92, issue.12, pp.355-62, 2016.
DOI : 10.1016/j.ymgme.2007.05.006

J. Pietz, R. Dunckelmann, A. Rupp, D. Rating, H. Meinck et al., Neurological outcome in adult patients with early-treated phenylketonuria, European Journal of Pediatrics, vol.157, issue.10, pp.824-854, 1998.
DOI : 10.1007/s004310050945

M. Robinson, F. White, M. Cleary, E. Wraith, W. Lam et al., Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet, The Journal of Pediatrics, vol.136, issue.4, pp.545-552, 2000.
DOI : 10.1016/S0022-3476(00)90022-2

M. Hoeks, M. Den-heijer, and M. Janssen, Adult issues in phenylketonuria, Neth J Med. janv, vol.67, issue.1, pp.2-7, 2009.

M. Cleary, J. Walter, J. Wraith, J. Jenkins, S. Alani et al., Magnetic resonance imaging of the brain in phenylketonuria, The Lancet, vol.344, issue.8915, pp.87-90, 1994.
DOI : 10.1016/S0140-6736(94)91281-5

B. Joseph and C. Dyer, Relationship between myelin production and dopamine synthesis in the PKU mouse brain, Journal of Neurochemistry, vol.76, issue.3, pp.615-641, 2003.
DOI : 10.1016/0005-2744(76)90111-X

R. Koch, B. Burton, G. Hoganson, R. Peterson, W. Rhead et al., Phenylketonuria in adulthood: a collaborative study, Journal of Inherited Metabolic Disease, vol.25, issue.5, pp.333-379, 2002.
DOI : 10.1023/A:1020158631102

S. Waisbren and H. Levy, Agoraphobia in phenylketonuria, Journal of Inherited Metabolic Disease, vol.176, issue.5, pp.755-64, 1991.
DOI : 10.1097/00005053-198810000-00007

A. Hoedt, L. De-sonneville, B. Francois, N. Horst, M. Janssen et al., High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial, Journal of Inherited Metabolic Disease, vol.155, issue.1, pp.165-71, 2011.
DOI : 10.1007/PL00014259

R. Gassió, J. Campistol, M. Vilaseca, N. Lambruschini, F. Cambra et al., Do adult patients with phenylketonuria improve their quality of life after introduction/resumption of a phenylalanine-restricted diet?, Acta Paediatrica, vol.51, issue.Suppl 2, pp.1474-1482, 2003.
DOI : 10.1111/j.1651-2227.2003.tb00834.x

K. Anjema, M. Van-rijn, P. Verkerk, J. Burgerhof, M. Heiner-fokkema et al., PKU: High plasma phenylalanine concentrations are associated with increased prevalence of mood swings, Molecular Genetics and Metabolism, vol.104, issue.3, pp.231-235, 2011.
DOI : 10.1016/j.ymgme.2011.05.017

K. Camp, M. Parisi, P. Acosta, G. Berry, D. Bilder et al., Phenylketonuria Scientific Review Conference: State of the science and future research needs, Molecular Genetics and Metabolism, vol.112, issue.2, pp.87-122, 2014.
DOI : 10.1016/j.ymgme.2014.02.013

J. Albrecht, S. Garbade, and P. Burgard, Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: A meta-analysis, Neuroscience & Biobehavioral Reviews, vol.33, issue.3, pp.414-435, 2009.
DOI : 10.1016/j.neubiorev.2008.11.001

P. Lee, M. Lilburn, and J. Baudin, Maternal phenylketonuria: experiences from the United Kingdom, Pediatrics, vol.112, pp.1553-1556, 2003.

H. Levy and M. Ghavami, Maternal phenylketonuria: A metabolic teratogen, Teratology, vol.85, issue.3, pp.176-84, 1996.
DOI : 10.1016/S0002-9378(11)90601-2

E. Werner, N. Blau, and B. Thöny, Tetrahydrobiopterin: biochemistry and pathophysiology, Biochemical Journal, vol.40, issue.3, pp.397-414, 2011.
DOI : 10.1002/humu.20700

URL : http://www.biochemj.org/content/ppbiochemj/438/3/397.full.pdf

C. Greene and N. Longo, National Institutes of Health (NIH) review of evidence in phenylalanine hydroxylase deficiency (phenylketonuria) and recommendations/guidelines for therapy from the American College of Medical Genetics (ACMG) and Genetics Metabolic Dietitians International (GMDI), Molecular Genetics and Metabolism, vol.112, issue.2, pp.85-91, 2014.
DOI : 10.1016/j.ymgme.2014.03.005

J. Dhondt, Lessons from 30??years of selective screening for tetrahydrobiopterin deficiency, Journal of Inherited Metabolic Disease, vol.1, issue.S2, pp.219-223, 2010.
DOI : 10.1007/s10545-010-9091-9

N. Blau, A. Bélanger-quintana, M. Demirkol, F. Feillet, M. Giovannini et al., Management of phenylketonuria in Europe: Survey results from 19 countries, Molecular Genetics and Metabolism, vol.99, issue.2, pp.109-124, 2010.
DOI : 10.1016/j.ymgme.2009.09.005

F. Van-spronsen and P. Burgard, The truth of treating patients with phenylketonuria after childhood: The need for a new guideline, Journal of Inherited Metabolic Disease, vol.15, issue.Supplement 2, pp.673-682, 2008.
DOI : 10.1136/bmj.314.7082.691

T. Hagedorn, P. Van-berkel, G. Hammerschmidt, M. Lhotáková, and R. Saludes, Requirements for a minimum standard of care for phenylketonuria: the patients??? perspective, Orphanet Journal of Rare Diseases, vol.8, issue.1, pp.1-8, 2013.
DOI : 10.1186/1750-1172-8-191

V. Abadie, J. Berthelot, F. Feillet, N. Maurin, A. Mercier et al., Consensus national sur la prise en charge des enfants d??pist??s avec une hyperph??nylalanin??mie, Archives de P??diatrie, vol.12, issue.5, pp.594-601, 2005.
DOI : 10.1016/j.arcped.2005.02.004

J. Vockley, H. Andersson, K. Antshel, N. Braverman, B. Burton et al., Phenylalanine hydroxylase deficiency: diagnosis and management guideline, Genetics in Medicine, vol.92, issue.2, pp.188-200, 2014.
DOI : 10.1002/humu.20526

URL : http://www.nature.com/gim/journal/v16/n2/pdf/gim2013157a.pdf

R. Singh, A. Cunningham, S. Mofidi, T. Douglas, D. Frazier et al., Updated, web-based nutrition management guideline for PKU: An evidence and consensus based approach, Molecular Genetics and Metabolism, vol.118, issue.2, pp.72-83, 2016.
DOI : 10.1016/j.ymgme.2016.04.008

L. Feux and F. , La phénylcétonurie [Internet]. Les Feux Follets, Disponible sur, 2016.

J. Walter, F. White, S. Hall, A. Macdonald, G. Rylance et al., How practical are recommendations for dietary control in phenylketonuria? Lancet. 6 juill, pp.55-62, 2002.
DOI : 10.1016/s0140-6736(02)09334-0

N. Blau, F. Van-spronsen, and H. Levy, Phenylketonuria, The Lancet, vol.376, issue.9750, pp.1417-1427, 2010.
DOI : 10.1016/S0140-6736(10)60961-0

Y. Okano and H. Nagasaka, Optimal serum phenylalanine for adult patients with phenylketonuria, Molecular Genetics and Metabolism, vol.110, issue.4, pp.424-454, 2013.
DOI : 10.1016/j.ymgme.2013.09.007

F. Feillet, Communication personnelle, Symposium PKU : a lifelong journey, p.2015

H. Autorité and D. Santé, Commission de la Transparence : KUVAN 100 mg, comprimé pour solution buvable, 2009.

S. Kure, D. Hou, T. Ohura, H. Iwamoto, S. Suzuki et al., Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency, The Journal of Pediatrics, vol.135, issue.3, pp.375-383, 1999.
DOI : 10.1016/S0022-3476(99)70138-1

R. Singh and M. Quirk, Using change in plasma phenylalanine concentrations and ability to liberalize diet to classify responsiveness to tetrahydrobiopterin therapy in patients with phenylketonuria, Molecular Genetics and Metabolism, vol.104, issue.4, pp.485-91, 2011.
DOI : 10.1016/j.ymgme.2011.09.009

F. Trefz, A. Muntau, F. Lagler, F. Moreau, J. Alm et al., The Kuvan?? Adult Maternal Paediatric European Registry (KAMPER) Multinational Observational Study: Baseline and 1-Year Data in Phenylketonuria Patients Responsive to Sapropterin, JIMD Rep, vol.23, pp.35-43, 2015.
DOI : 10.1007/8904_2015_425

R. Matalon, K. Michals-matalon, G. Bhatia, E. Grechanina, P. Novikov et al., Large neutral amino acids in the treatment of phenylketonuria (PKU), Journal of Inherited Metabolic Disease, vol.25, issue.3, pp.732-740, 2006.
DOI : 10.1148/radiology.201.2.8888233

R. Singh, F. Rohr, D. Frazier, A. Cunningham, S. Mofidi et al., Recommendations for the nutrition management of phenylalanine hydroxylase deficiency, Genetics in Medicine, vol.112, issue.2, pp.121-152, 2014.
DOI : 10.1023/A:1010546000617

D. Van-vliet, V. Bruinenberg, P. Mazzola, M. Van-faassen, P. De-blaauw et al., Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice, PLOS ONE, vol.401, issue.3, p.143833, 2015.
DOI : 10.1371/journal.pone.0143833.s004

J. Pietz, R. Kreis, A. Rupp, E. Mayatepek, D. Rating et al., Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria, Journal of Clinical Investigation, vol.103, issue.8, p.1169, 1999.
DOI : 10.1172/JCI5017

J. Rocha and F. Martel, Large neutral amino acids supplementation in phenylketonuric patients, Journal of Inherited Metabolic Disease, vol.25, issue.4, pp.472-80, 2009.
DOI : 10.1203/00006450-199511000-00005

O. Zaki, L. El-wakeel, Y. Ebeid, E. Elarab, H. Moustafa et al., The Use of Glycomacropeptide in Dietary Management of Phenylketonuria, Journal of Nutrition and Metabolism, vol.38, issue.3, abstract 81, pp.1-5, 2016.
DOI : 10.1016/j.ymgme.2010.04.003

C. Sarkissian, A. Gámez, L. Wang, M. Charbonneau, P. Fitzpatrick et al., Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria, Proceedings of the National Academy of Sciences, vol.29, issue.2, pp.20894-20903, 2008.
DOI : 10.1016/0278-6915(91)90163-2

Z. Ding, C. Harding, A. Rebuffat, L. Elzaouk, J. Wolff et al., Correction of Murine PKU Following AAV-mediated Intramuscular Expression of a Complete Phenylalanine Hydroxylating System, Molecular Therapy, vol.16, issue.4, pp.673-81, 2008.
DOI : 10.1038/mt.2008.17

A. Hafid, N. Christodoulou, and J. , Phenylketonuria: a review of current and future treatments, Transl Pediatr, vol.4, issue.4, pp.304-321, 2015.

K. Hargreaves and W. Pardridge, Neutral amino acid transport at the human blood-brain barrier, J Biol Chem, vol.263, issue.36, pp.19392-19399, 1988.

Q. Smith, Transport of glutamate and other amino acids at the blood-brain barrier, J Nutr, vol.130, issue.4, pp.1016-1038, 2000.

W. Pardridge, Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids, Neurochemical Research, vol.23, issue.5, pp.635-679, 1998.
DOI : 10.1023/A:1022482604276

C. Mckean, The effects of high phenylalanine concentrations on serotinin and catecholamine metabolism in the human brain, Brain Research, vol.47, issue.2, pp.469-76, 1972.
DOI : 10.1016/0006-8993(72)90653-1

T. Pascucci, R. Ventura, S. Puglisi-allegra, and S. Cabib, Deficits in brain serotonin synthesis in a genetic mouse model of phenylketonuria, NeuroReport, vol.13, issue.18, pp.2561-2565, 2002.
DOI : 10.1097/00001756-200212200-00036

A. Burlina, L. Bonafé, V. Ferrari, A. Suppiej, F. Zacchello et al., Measurement of neurotransmitter metabolites in the cerebrospinal fluid of phenylketonuric patients under dietary treatment, Journal of Inherited Metabolic Disease, vol.23, issue.4, pp.313-319, 2000.
DOI : 10.1023/A:1005694122277

H. Kalkano?lu, K. Ahring, D. Sertkaya, L. Møller, A. Romstad et al., Behavioural effects of phenylalanine-free amino acid tablet supplementation in intellectually disabled adults with untreated phenylketonuria, Acta Paediatrica, vol.148, issue.9, pp.1218-1240, 2005.
DOI : 10.1111/j.1651-2227.2005.tb02078.x

M. De-groot, M. Hoeksma, N. Blau, D. Reijngoud, and F. Van-spronsen, Pathogenesis of cognitive dysfunction in phenylketonuria: Review of hypotheses???, Molecular Genetics and Metabolism, vol.99, pp.86-95, 2010.
DOI : 10.1016/j.ymgme.2009.10.016

S. Ogawa and H. Ichinose, Effect of metals and phenylalanine on the activity of human tryptophan hydroxylase-2: Comparison with that on tyrosine hydroxylase activity, Neuroscience Letters, vol.401, issue.3, pp.261-266, 2006.
DOI : 10.1016/j.neulet.2006.03.031

T. Pascucci, D. Andolina, I. Mela, D. Conversi, C. Latagliata et al., 5-Hydroxytryptophan rescues serotonin response to stress in prefrontal cortex of hyperphenylalaninaemic mice, The International Journal of Neuropsychopharmacology, vol.12, issue.08, pp.1067-79, 2009.
DOI : 10.1017/S1461145709990381

J. Weglage, D. Wiedermann, H. Möller, and K. Ullrich, Pathogenesis of different clinical outcomes in spite of identical genotypes and comparable blood phenylalanine concentrations in phenylketonurics, Journal of Inherited Metabolic Disease, vol.21, issue.2, pp.181-183, 1998.
DOI : 10.1023/A:1005328717095

S. Winn, T. Scherer, B. Thöny, and C. Harding, High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU), Molecular Genetics and Metabolism, vol.117, issue.1, pp.5-11, 2016.
DOI : 10.1016/j.ymgme.2015.11.012

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706464/pdf

H. Haruki, R. Hovius, M. Pedersen, and K. Johnsson, Tetrahydrobiopterin Biosynthesis as a Potential Target of the Kynurenine Pathway Metabolite Xanthurenic Acid, Journal of Biological Chemistry, vol.73, issue.2, pp.652-659, 2016.
DOI : 10.1016/j.pnpbp.2012.10.006

W. Kochen, D. Byrd, R. Bühner, and E. Bührlen, Tryptophan metabolism in untreated phenylketonuria and in vitamin B6 dependent cramps, Z Für Klin Chem Klin Biochem. avr, vol.10, issue.4, p.180, 1972.

W. Kochen, D. Byrd, R. Bühner, and E. Bühlen, Studies on tryptophan metabolism in untreated phenylketonuric patients, Z Für Klin Chem Klin Biochem. janv, vol.13, issue.1, pp.1-12, 1975.

C. Godin and G. Dolan, Tryptophan metabolism in normal and phenylketonuric rats, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.130, issue.2, pp.535-542, 1966.
DOI : 10.1016/0304-4165(66)90255-8

D. Byrd, W. Kochen, L. Schürrle, and F. Trefz, A study of urinary tryptophan metabolites in relation to the phenylalanine content of semi-synthetic diets in a patient with phenylketonuria, Acta Vitaminol Enzymol, vol.29, issue.1?6, pp.55-61, 1975.

D. Milovanovi?, L. Milovanovi?, and D. Vranjesevi?, Serum Tryptophan to Large Neutral Amino Acid Ratio and Urinary Tryptophan in Three Patients with Phenylketonuria in a Family, Adv Exp Med Biol, vol.467, pp.289-95, 1999.
DOI : 10.1007/978-1-4615-4709-9_37

E. Turner, J. Loftis, and A. Blackwell, Serotonin a la carte: Supplementation with the serotonin precursor 5-hydroxytryptophan, Pharmacology & Therapeutics, vol.109, issue.3, pp.325-363, 2006.
DOI : 10.1016/j.pharmthera.2005.06.004

Y. Chen and G. Guillemin, Kynurenine pathway metabolites in humans: disease and healthy states, Int J Tryptophan Res, vol.21, 2009.

D. Cheillan, S. Cognat, C. Vianey-saban, I. Maire, and C. Dorche, Application of tandem mass spectrometry to neonatal screening of inherited metabolic diseases: focus on present developments, Ann Biol Clin. juin, vol.62, issue.3, pp.269-77, 2004.

X. Xiang, Y. Han, M. Neuvonen, J. Laitila, P. Neuvonen et al., High performance liquid chromatography???tandem mass spectrometry for the determination of bile acid concentrations in human plasma, Journal of Chromatography B, vol.878, issue.1, pp.51-60, 2010.
DOI : 10.1016/j.jchromb.2009.11.019

A. Norme, N. En, and . Iso, Exigences concernant la qualité et la compétence, 2013.

F. Peters, O. Drummer, and F. Musshoff, Validation of new methods, Forensic Science International, vol.165, issue.2-3, pp.216-240, 2007.
DOI : 10.1016/j.forsciint.2006.05.021

B. Matuszewski, M. Constanzer, and C. Chavez-eng, Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC???MS/MS, Analytical Chemistry, vol.75, issue.13, pp.3019-3049, 2003.
DOI : 10.1021/ac020361s

C. Ricós, V. Alvarez, F. Cava, J. García-lario, A. Hernández et al., Current databases on biological variation: pros, cons and progress, Scand J Clin Lab Invest. nov, vol.59, issue.7, pp.491-500, 1999.

I. Kema, E. De-vries, A. Schellings, P. Postmus, and F. Muskiet, Improved diagnosis of carcinoid tumors by measurement of platelet serotonin, Clin Chem. avr, vol.38, issue.4, pp.534-574, 1992.

M. Favennec, B. Hennart, R. Caiazzo, A. Leloire, L. Yengo et al., The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation. Obes Silver Spring Md, 2015.

J. Gostner, K. Becker, K. Kurz, and D. Fuchs, Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms, Frontiers in Psychiatry, vol.6, p.97, 2015.
DOI : 10.3389/fpsyt.2015.00097

L. Boulet, Mise au point du dosage sanguin des m??tabolites de la voie du tryptophane en HPLC-MS/MS et perspectives dans le suivi biologique des patients atteints de ph??nylc??tonurie, Archives de P??diatrie, vol.23, issue.10, 2016.
DOI : 10.1016/j.arcped.2016.07.021

H. Zuo, P. Ueland, A. Ulvik, S. Eussen, S. Vollset et al., Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality, American Journal of Epidemiology, vol.183, issue.4, 2016.
DOI : 10.1093/aje/kwv242

O. Deac, J. Mills, B. Shane, Ø. Midttun, P. Ueland et al., Tryptophan Catabolism and Vitamin B-6 Status Are Affected by Gender and Lifestyle Factors in Healthy Young Adults, Journal of Nutrition, vol.145, issue.4, pp.701-708, 2015.
DOI : 10.3945/jn.114.203091

URL : http://jn.nutrition.org/content/145/4/701.full.pdf

O. Midttun, M. Townsend, O. Nygård, S. Tworoger, P. Brennan et al., Most Blood Biomarkers Related to Vitamin Status, One-Carbon Metabolism, and the Kynurenine Pathway Show Adequate Preanalytical Stability and Within-Person Reproducibility to Allow Assessment of Exposure or Nutritional Status in Healthy Women and Cardiovascular Patients, Journal of Nutrition, vol.144, issue.5, pp.784-90, 2014.
DOI : 10.3945/jn.113.189738

R. Carling, T. Degg, K. Allen, N. Bax, and J. Barth, Evaluation of Whole Blood Serotonin and Plasma and Urine 5-Hydroxyindole Acetic Acid in Diagnosis of Carcinoid Disease, Annals of Clinical Biochemistry: An international journal of biochemistry and laboratory medicine, vol.39, issue.6, pp.577-82, 2002.
DOI : 10.1177/000456320203900605

S. Hustad, S. Eussen, O. Midttun, A. Ulvik, P. Van-de-kant et al., Kinetic Modeling of Storage Effects on Biomarkers Related to B Vitamin Status and One-Carbon Metabolism, Clinical Chemistry, vol.58, issue.2, pp.402-412, 2012.
DOI : 10.1373/clinchem.2011.174490

R. Xiao, O. Beck, and P. Hjemdahl, On the accurate measurement of serotonin in whole blood, Scandinavian Journal of Clinical and Laboratory Investigation, vol.38, issue.7, pp.505-515, 1998.
DOI : 10.1016/0006-2944(70)90010-4